An interventional study of JuggerStitch Meniscal Repair Device in Meniscus Tear, Tibial and Meniscus Lesion, sponsored by Zimmer Biomet. Completed at 6 sites in 4 countries. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-24.
Sponsored by Zimmer Biomet · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This study is a post-market follow-up study. The data collected from this study will serve the purpose of confirming the safety and performance of the JuggerStitch Device used for meniscal repair according to the product labelling (Instruction For Use).
This study is a post-market follow-up study to fulfil the post-market surveillance obligations according to Medical Device Directive and MEDDEV 2.12/2 and the Medical Devices Regulation (MDR 2017/745). The data collected from this study will serve the purpose of confirming the safety and performance of the JuggerStitch Device used for meniscal repair according to the product labelling (IFU).
The objectives of the study are to calculate the overall clinical success rate and the performance, and confirm the safety of the JuggerStitch Meniscal Repair Device. The primary endpoint of this study is defined by the absence of reoperation due to meniscal tear. This will be measured against the success criteria of the absence of reoperation in 90.2% of the cases at one year.
Zimmer Biomet is the lead sponsor of 275 studies on the registry; 28 are open to participants now.
Of its 22 completed or terminated interventional studies of FDA-regulated products, 19 (86%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients in need of meniscal repair
Device: JuggerStitch Meniscal Repair Device
Treatment of torn meniscus with JuggerStitch.
Clinical Success
The absence of reoperation due to meniscal tear. This will be measured against the success criteria of the absence of reoperation in 90.2% of the cases at 1 year. Clinical success was defined as the absence of reoperation of the index knee due to a meniscal tear from the date of surgery through the participant's last available follow-up. All participants included in the analysis had at least 1 year of follow-up, and follow-up beyond 1 year was included when available.
Time frame: From the date of surgery through the participant's last available follow-up; minimum follow-up of 1 year and mean follow-up of 3.2 years
Number of Adverse Events
The total number of adverse events reported from the date of surgery through each participant's last available follow-up was assessed to evaluate the safety of the JuggerStitch Meniscal Repair Device. Events were included regardless of seriousness or assessed relationship to the device, instrumentation, or procedure.
Time frame: From the date of surgery through the participant's last available follow-up; minimum follow-up of 1 year and mean follow-up of 3.2 years
Lysholm Knee Scoring Scale Score
The Lysholm Knee Scoring Scale assesses knee symptoms and function based on pain, instability, locking, swelling, limp, stair climbing, squatting, and the need for support. The total score ranges from 0 to 100, with higher scores indicating better knee function and fewer symptoms.
Time frame: Pre-operatively, 6 weeks, 6 months and 1 year post-surgery
Tegner Activity Scale Score
The Tegner Activity Scale assesses participation in work and sports activities. Scores range from 0 to 10, where 0 indicates sick leave or disability because of knee problems and 10 indicates participation in competitive elite sports. Higher scores indicate a higher level of physical activity.
Time frame: Preoperatively and at 6 weeks, 6 months, and 1 year postoperatively
International Knee Documentation Committee Subjective Knee Evaluation Form Score
The International Knee Documentation Committee Subjective Knee Evaluation Form assesses knee symptoms, function, and ability to participate in sports activities. The total score ranges from 0 to 100, with higher scores indicating fewer symptoms, better knee function, and a better outcome.
Time frame: Preoperatively and at 6 weeks, 6 months, and 1 year postoperatively
Number of Participants by Joint Line Tenderness Test Result
The Joint Line Tenderness Test was performed during clinical examination by palpating the medial and lateral joint lines of the operated knee. The test was considered positive when palpation elicited joint line pain or tenderness and negative when no joint line pain or tenderness was elicited. Results are reported as the number of participants with positive and negative findings at each assessment.
Time frame: Preoperatively and at 6 weeks, 6 months, and 1 year postoperatively
Number of Participants by McMurray Test Result
The McMurray Test was performed during the clinical examination of the operated knee using knee flexion and extension with tibial rotation and applied varus or valgus stress. The test was considered positive when pain, snapping, an audible or palpable click, or locking suggestive of meniscal pathology was elicited. The test was considered negative when none of these findings was present. Results are reported as the number of participants with positive and negative test findings at each assessment.
Time frame: Preoperatively and at 6 weeks, 6 months, and 1 year postoperatively
| Milestone | Meniscal Repair |
|---|---|
| Started | 103 |
| Completed | 103 |
| Not completed | 0 |
The absence of reoperation due to meniscal tear. This will be measured against the success criteria of the absence of reoperation in 90.2% of the cases at 1 year. Clinical success was defined as the absence of reoperation of the index knee due to a meniscal tear from the date of surgery through the participant's last available follow-up. All participants included in the analysis had at least 1 year of follow-up, and follow-up beyond 1 year was included when available.
| Participants | Meniscal Repair |
|---|---|
| Clinical Success | 101 |
The total number of adverse events reported from the date of surgery through each participant's last available follow-up was assessed to evaluate the safety of the JuggerStitch Meniscal Repair Device. Events were included regardless of seriousness or assessed relationship to the device, instrumentation, or procedure.
| Adverse Events | Meniscal Repair |
|---|---|
| Number of Adverse Events | 10 |
The Lysholm Knee Scoring Scale assesses knee symptoms and function based on pain, instability, locking, swelling, limp, stair climbing, squatting, and the need for support. The total score ranges from 0 to 100, with higher scores indicating better knee function and fewer symptoms.
| units on a scale | Meniscal Repair |
|---|---|
| Preoperative | 56.0 ± 22.0 |
| 6 Weeks Postoperatively | 63.3 ± 19.9 |
| 6 Months Postoperatively | 85.0 ± 16.2 |
| 1 Year Postoperatively | 89.0 ± 12.5 |
The Tegner Activity Scale assesses participation in work and sports activities. Scores range from 0 to 10, where 0 indicates sick leave or disability because of knee problems and 10 indicates participation in competitive elite sports. Higher scores indicate a higher level of physical activity.
| units on a scale | Meniscal Repair |
|---|---|
| Preoperative | 2.6 ± 1.4 |
| 6 Weeks Postoperatively | 2.1 ± 1.0 |
| 6 Months Postoperatively | 4.0 ± 1.6 |
| 1 Year Postoperatively | 5.4 ± 1.9 |
The International Knee Documentation Committee Subjective Knee Evaluation Form assesses knee symptoms, function, and ability to participate in sports activities. The total score ranges from 0 to 100, with higher scores indicating fewer symptoms, better knee function, and a better outcome.
| units on a scale | Meniscal Repair |
|---|---|
| Preoperative | 46.3 ± 13.0 |
| 6 Week Postoperative | 39.1 ± 10.6 |
| 6 Months Postoperative | 60.0 ± 9.8 |
| 1 Year Postoperative | 66.0 ± 10.1 |
The Joint Line Tenderness Test was performed during clinical examination by palpating the medial and lateral joint lines of the operated knee. The test was considered positive when palpation elicited joint line pain or tenderness and negative when no joint line pain or tenderness was elicited. Results are reported as the number of participants with positive and negative findings at each assessment.
| Participants | Meniscal Repair |
|---|---|
| Preoperative Negative Outcome | 41 |
| Preoprative Positive Outcome | 54 |
| 6 Week Negative Outcome | 54 |
| 6 Week Positive Outcome | 38 |
| 6 Months Negative Outcome | 63 |
| 6 Months Positive Outcome | 17 |
| 1 Year Negative Outcome | 70 |
| 1 Year Positive Outcome | 12 |
The McMurray Test was performed during the clinical examination of the operated knee using knee flexion and extension with tibial rotation and applied varus or valgus stress. The test was considered positive when pain, snapping, an audible or palpable click, or locking suggestive of meniscal pathology was elicited. The test was considered negative when none of these findings was present. Results are reported as the number of participants with positive and negative test findings at each assessment.
| Participants | Meniscal Repair |
|---|---|
| Preoperative — Negative Outcome | 46 |
| Preoperative — Positive Outcome | 48 |
| 6 Weeks Postoperative — Negative Outcome | 79 |
| 6 Weeks Postoperative — Positive Outcome | 11 |
| 6 Month Postoperative — Negative Outcome | 71 |
| 6 Month Postoperative — Positive Outcome | 9 |
| 1 Year Postoperative — Negative Outcome | 78 |
| 1 Year Postoperative — Positive Outcome | 4 |
Collected over From the date of surgery through the participant's last available follow-up; all participants had at least 1 year of follow-up, and follow-up continued beyond 1 year where available. The mean follow-up duration was 3.2 years.. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Meniscal Repair | 0/103 (0%) | 3/103 (2.9%) | 7/103 (6.8%) |
| Event | Meniscal Repair |
|---|---|
| Meniscal injuryMusculoskeletal and connective tissue disorders | 1/103 |
| Ligament injuryMusculoskeletal and connective tissue disorders | 1/103 |
| Device dislocationInjury, poisoning and procedural complications | 1/103 |
| Event | Meniscal Repair |
|---|---|
| COVID-19Infections and infestations | 1/103 |
| Implant site inflammationGeneral disorders | 1/103 |
| Muscle ruptureMusculoskeletal and connective tissue disorders | 1/103 |
| Meniscal injuryMusculoskeletal and connective tissue disorders | 1/103 |
| ChondromalaciaMusculoskeletal and connective tissue disorders | 1/103 |
| Surgical site infectionInfections and infestations | 1/103 |
| Joint stiffnessMusculoskeletal and connective tissue disorders | 1/103 |
| Age, Continuous(years) | Meniscal Repair |
|---|---|
| Mean | 37.0 ± 15.5 |
| Sex: Female, Male(Participants) | Meniscal Repair |
|---|---|
| Female | 30 |
| Male | 73 |
| Race and Ethnicity Not Collected(Participants) | Meniscal Repair |
|---|
| Region of Enrollment(participants) | Meniscal Repair |
|---|---|
| United States | 29 |
| Japan | 53 |
| France | 13 |
| Germany | 8 |
| Body Mass Index of participants(kilograms per square meter) | Meniscal Repair |
|---|---|
| Mean | 24.2 ± 3.2 |
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No
Ran from Sep 2020 to primary completion in Apr 2026, 67 months.
Results were first posted in Sep 2026, 4 months after primary completion.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Tibial Meniscus Injuries